Product NDC: | 45802-616 |
Proprietary Name: | Perrigo Citalopram |
Non Proprietary Name: | Citalopram |
Active Ingredient(s): | 40 mg/1 & nbsp; Citalopram |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-616 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077042 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041118 |
Package NDC: | 45802-616-65 |
Package Description: | 30 TABLET in 1 BOTTLE (45802-616-65) |
NDC Code | 45802-616-65 |
Proprietary Name | Perrigo Citalopram |
Package Description | 30 TABLET in 1 BOTTLE (45802-616-65) |
Product NDC | 45802-616 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Citalopram |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20041118 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | CITALOPRAM HYDROBROMIDE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |